VFP Pharmacy Group, a portfolio company of BelHealth Investment Partners, a healthcare private equity firm based in Fort Lauderdale, FL, secured $12 million in debt financing from ORIX USA’s growth capital team.
VFP is a U.S. fertility pharmacy. The transaction with ORIX provides VFP the necessary working capital to continue its growth as the fertility sector experiences strong tailwinds.
“We are thrilled to have ORIX USA’s growth capital team as a partner,” Richard J. Burkett, CEO and board director at VFP Pharmacy Group, said. “The pharmacy is an integral part of the fertility journey and VFP prides itself on being a reliable and caring partner during this exciting path to parenthood.”
“We have been impressed with VFP’s commitment to service, including its strong positioning in the fertility sector, and are excited to work closely with the VFP team and BelHealth,” David Orlandella, managing director of ORIX USA’s growth capital group, said.
“I have enjoyed working closely with the ORIX USA’s growth capital team to complete this transaction,” Brett Bleau, CFO of VFP Pharmacy Group, said. “This financing not only supports our working capital needs relative to the company’s current growth, which has out-paced the industry by several fold, but also enables us to establish the technology and infrastructure to enhance patient experience and drive increased demand for our products and services.”
